A newly recognized form of diabetes, Type 3c Diabetes Mellitus (T3cDM), has now gained formal acknowledgment within the medical community. Unlike Type 1 (autoimmune-mediated) or Type 2 (driven largely by insulin resistance), Type 3c arises as a direct consequence of pancreatic disease or injury including chronic pancreatitis, cystic fibrosis, pancreatic surgery, or pancreatic cancer.


Because the pancreas plays a dual role in both blood sugar regulation and digestion, its dysfunction leads to unique challenges. Unfortunately, many patients with T3cDM are still misdiagnosed as having Type 2 diabetes, resulting in suboptimal treatment. Correct diagnosis is critical, as patients often require both insulin therapy and pancreatic enzyme replacement therapy to address the combined metabolic and digestive impairments.
Recognizing T3cDM matters. It enables clinicians to deliver more precise care, improve outcomes, and raise awareness of a form of diabetes that remains hidden under the shadow of more familiar types.


Meanwhile, the term “Type 3 Diabetes” has surfaced in neuroscience discussions, referring to brain insulin resistance and its potential link to Alzheimer’s disease. While intriguing, this connection is still under investigation and has not yet been formally adopted into clinical classification.

In short, distinguishing T3cDM represents a major step forward—shaping better diagnosis, more effective treatment, and a deeper understanding of how diverse the spectrum of diabetes truly is.



References
1. Hart P.A. et al. Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer. The Lancet Gastroenterology & Hepatology. [PMC]
2. Milani I. et al. (2025). The Challenge of Type 3c Diabetes: From Accurate Diagnosis to Rational Management. [PMC]
3. Ewald N. et al. Diabetes mellitus secondary to pancreatic diseases (Type 3c). European Journal of Internal Medicine. [EJINME]
4. Diabetes Care (2008). Is Pancreatic Diabetes (Type 3c Diabetes) Underdiagnosed? [Diabetes Journals]
5. Conlon K.C. & Duggan S.N. (2017). Pancreatogenic Type 3c Diabetes: Underestimated, Underappreciated and Poorly Managed. Practical Gastroenterology/Nutrition Issues in Gastroenterology. [UVA School of Medicine]